European Commission 28 October 2009, Commission Regulation (EC) No 1050/2009 of 28 October 2009 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, acetamiprid, clomazone, cyflufenamid, emamectin benzoate, famoxadone, fenbutatin oxide, flufenoxuron, fluopicolide, indoxacarb, ioxynil, mepanipyrim, prothioconazole, pyridalyl, thiacloprid and trifloxystrobin in or on certain products (Text with EEA relevance)

Also known as

European Union · · · Cited by 72 · 06-11-2009

6.11.2009

Official Journal of the European Union

L 290/7

COMMISSION REGULATION (EC) No 1050/2009

of 28 October 2009

amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, acetamiprid, clomazone, cyflufenamid, emamectin benzoate, famoxadone, fenbutatin oxide, flufenoxuron,

Read the full text

This document is published by eur-lex.europa.eu.

Moonlit adds the citation network (72 references), article-level links and cross-references, which are available to search for free.